131 related articles for article (PubMed ID: 3198307)
1. Rosmarinic acid: a new inhibitor of complement C3-convertase with anti-inflammatory activity.
Englberger W; Hadding U; Etschenberg E; Graf E; Leyck S; Winkelmann J; Parnham MJ
Int J Immunopharmacol; 1988; 10(6):729-37. PubMed ID: 3198307
[TBL] [Abstract][Full Text] [Related]
2. The inhibitory effect of rosmarinic acid on complement involves the C5 convertase.
Peake PW; Pussell BA; Martyn P; Timmermans V; Charlesworth JA
Int J Immunopharmacol; 1991; 13(7):853-7. PubMed ID: 1761351
[TBL] [Abstract][Full Text] [Related]
3. Anti-complement activity of oleanolic acid: an inhibitor of C3-convertase of the classical complement pathway.
Kapil A; Sharma S
J Pharm Pharmacol; 1994 Nov; 46(11):922-3. PubMed ID: 7897600
[TBL] [Abstract][Full Text] [Related]
4. Anticomplementary activity of boswellic acids--an inhibitor of C3-convertase of the classical complement pathway.
Kapil A; Moza N
Int J Immunopharmacol; 1992 Oct; 14(7):1139-43. PubMed ID: 1452399
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of complement by covalent attachment of rosmarinic acid to activated C3b.
Sahu A; Rawal N; Pangburn MK
Biochem Pharmacol; 1999 Jun; 57(12):1439-46. PubMed ID: 10353266
[TBL] [Abstract][Full Text] [Related]
6. FUT-175 as a potent inhibitor of C5/C3 convertase activity for production of C5a and C3a.
Inagi R; Miyata T; Maeda K; Sugiyama S; Miyama A; Nakashima I
Immunol Lett; 1991 Jan; 27(1):49-52. PubMed ID: 2019419
[TBL] [Abstract][Full Text] [Related]
7. Hybrid proteins of Cobra Venom Factor and cobra C3: tools to identify functionally important regions in Cobra Venom Factor.
Hew BE; Wehrhahn D; Fritzinger DC; Vogel CW
Toxicon; 2012 Sep; 60(4):632-47. PubMed ID: 22609532
[TBL] [Abstract][Full Text] [Related]
8. A cobra venom factor (CVF)-induced C3 convertase activity in the hemolymph of Galleria mellonella.
Phipps D; Menger M; Chadwick JS; Aston WP
Dev Comp Immunol; 1987; 11(1):37-46. PubMed ID: 3647909
[TBL] [Abstract][Full Text] [Related]
9. Regulation of the amplification C3 convertase of human complement by an inhibitory protein isolated from human erythrocyte membrane.
Fearon DT
Proc Natl Acad Sci U S A; 1979 Nov; 76(11):5867-71. PubMed ID: 293688
[TBL] [Abstract][Full Text] [Related]
10. Complement-dependent stimulation of prostacyclin biosynthesis: inhibition by rosmarinic acid.
Rampart M; Beetens JR; Bult H; Herman AG; Parnham MJ; Winkelmann J
Biochem Pharmacol; 1986 Apr; 35(8):1397-400. PubMed ID: 3516156
[No Abstract] [Full Text] [Related]
11. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
Brown EJ; Ramsey J; Hammer CH; Frank MM
J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
[TBL] [Abstract][Full Text] [Related]
12. In vitro inhibition of the classical pathway of human complement by a natural microbial product, colistin sulphate.
Asghar SS; de Koster A; van der Helm HJ
Biochem Pharmacol; 1986 Sep; 35(17):2917-21. PubMed ID: 3638137
[TBL] [Abstract][Full Text] [Related]
13. Methionine modification impairs the C5-cleavage function of cobra venom factor-dependent C3/C5 convertase.
Fu Q; McPhie P; Gowda DC
Biochem Mol Biol Int; 1998 Jun; 45(1):133-44. PubMed ID: 9635137
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes.
Medof ME; Kinoshita T; Nussenzweig V
J Exp Med; 1984 Nov; 160(5):1558-78. PubMed ID: 6238120
[TBL] [Abstract][Full Text] [Related]
15. Ultrastructure of cobra venom factor-dependent C3/C5 convertase and its zymogen, factor B of human complement.
Smith CA; Vogel CW; Müller-Eberhard HJ
J Biol Chem; 1982 Sep; 257(17):9879-82. PubMed ID: 6921201
[TBL] [Abstract][Full Text] [Related]
16. Recombinant cobra venom factor.
Vogel CW; Fritzinger DC; Hew BE; Thorne M; Bammert H
Mol Immunol; 2004 Jun; 41(2-3):191-9. PubMed ID: 15159065
[TBL] [Abstract][Full Text] [Related]
17. Functional assay of C5-activating and nonactivating cobra venom factor preparations in the mouse system.
Van den Berg CW; Aerts PC; Van Dijk H
J Immunol Methods; 1990 Oct; 133(2):199-206. PubMed ID: 2230138
[TBL] [Abstract][Full Text] [Related]
18. The cobra venom factor-dependent C3 convertase of human complement. A kinetic and thermodynamic analysis of a protease acting on its natural high molecular weight substrate.
Vogel CW; Müller-Eberhard HJ
J Biol Chem; 1982 Jul; 257(14):8292-9. PubMed ID: 6919543
[No Abstract] [Full Text] [Related]
19. Interaction of desialated guinea pig erythrocytes with the classical and alternative pathways of guinea pig complement in vivo and in vitro.
Brown EJ; Joiner KA; Frank MM
J Clin Invest; 1983 Jun; 71(6):1710-9. PubMed ID: 6863540
[TBL] [Abstract][Full Text] [Related]
20. In vitro inhibition of the classical pathway of human complement by polymyxin B.
Asghar SS; Boot T; van der Helm HJ
Biochem Pharmacol; 1987 Sep; 36(18):2927-30. PubMed ID: 2820426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
